drugset / Trial / NCT03688269
Minimal Effective Concentration (EC90) of Ropivacaine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Prospective up and down sequential evaluation of the minimal effective concentration of perineural ropivacaine for 90% success in axillary brachial plexus block with the injection of intravenous dexamethasone or saline placebo during regional anesthesia performance
Timeline
- Start
- 2018-10-05
- Primary completion
- 2019-11-04
- Completion
- 2020-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 8 mg | Intravenous |
| Subject | Ropivacaine | Other / unclassified | 20 ml | Other |
Indications
No indication recorded.